000			01736 a2200469 4500
005			20250514232403.0
264		0	_c20060106
008			200601s 0 0 eng d
022			_a1525-0016
024	7		_a10.1016/j.ymthe.2005.04.020 _2doi
040			_aNLM _beng _cNLM
100	1		_aCheng, Wen-Fang
245	0	0	_aAntigen-specific CD8+ T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway. _h[electronic resource]
260			_bMolecular therapy : the journal of the American Society of Gene Therapy _cNov 2005
300			_a960-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aCD8-Positive T-Lymphocytes _ximmunology
650	0	4	_aCancer Vaccines
650	0	4	_aCell Line, Tumor
650	0	4	_aDown-Regulation
650	0	4	_aFas Ligand Protein
650	0	4	_aFemale
650	0	4	_aGenetic Therapy
650	0	4	_aHistocompatibility Antigens Class I
650	0	4	_aInterferon-gamma _xmetabolism
650	0	4	_aMembrane Glycoproteins _xbiosynthesis
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aNeoplasms, Experimental _xmetabolism
650	0	4	_aT-Lymphocytes, Cytotoxic _xmetabolism
650	0	4	_aTumor Necrosis Factors _xbiosynthesis
650	0	4	_aVaccines, DNA
650	0	4	_afas Receptor _xmetabolism
700	1		_aLee, Chien-Nan
700	1		_aChang, Ming-Cheng
700	1		_aSu, Yi-Ning
700	1		_aChen, Chi-An
700	1		_aHsieh, Chang-Yao
773	0		_tMolecular therapy : the journal of the American Society of Gene Therapy _gvol. 12 _gno. 5 _gp. 960-8
856	4	0	_uhttps://doi.org/10.1016/j.ymthe.2005.04.020 _zAvailable from publisher's website
999			_c15637564 _d15637564